Resources for students such as educational tools covering a variety of managed care topics and information on professional opportunities (internships, APPEs, fellowships and residencies) related to managed care pharmacy.
President Donald Trump announced a series of agreements with Eli Lilly and Company and Novo Nordisk to offer Most-Favored-Nation (MFN) prices on two GLP-1 therapies, semaglutide (brand names Ozempic and Wegovy) and tirzepatide (brand names Mounjaro and Zepbound). This marks the fourth and fifth publicly announced agreements between the Trump administration and pharmaceutical manufacturers, joining earlier announcements with Pfizer, AstraZeneca, and EMD Serono. The manufacturers also agreed to cap prices for insulin products and other commonly prescribed diabetes medications.
Read the Journal of Managed Care + Specialty Pharmacy (JMCP) - November 2025 Issue
The Academy of Managed Care Pharmacy (AMCP), in partnership with the AMCP Research Institute, published the 2025 edition of its annual Access, Affordability, and Outcomes: The Value of Managed Care Pharmacy report, which provides an in-depth look at how managed care pharmacy practices improve patient health outcomes, control prescription drug spending, and promote affordability for millions of Americans.
On July 4, 2025, President Trump signed H.R. 1, the Reconciliation Bill (aka the “One Big Beautiful Bill Act”) into law, which includes significant policy changes to Medicaid and the Health Insurance Marketplaces.
AMCP developed this first-of-its-kind report focused on the managed care pharmacy workforce. The objectives of this report are threefold: to describe the composition of the workforce, to serve as a valuable resource f or individuals and organizations, and to capture pharmacists’ perspectives on key workforce-related issues. The 2025 Managed Care Pharmacy Workforce Report represents a significant step toward a deeper understanding of the managed care pharmacy landscape.
On Saturday, October 11, Governor Gavin Newsom signed SB 41, a bill that limits certain business practices employed by pharmacy benefit managers (PBMs) in California. This bill follows previous attempts by the governor to regulate PBMs, including changes implemented in the budget that require PBMs to obtain a license, submit detailed operational and financial statements annually to the Department of Managed Health Care, and act in the best interests of health plans and covered individuals.
The Academy of Managed Care Pharmacy (AMCP) released a first-of-its-kind Managed Care Pharmacy Workforce Report, providing a comprehensive look at the state of the managed care pharmacy profession.
AMCP developed this first-of-its-kind report focused on the managed care pharmacy workforce. The objectives of this report are threefold: to describe the composition of the workforce, to serve as a valuable resource f or individuals and organizations, and to capture pharmacists’ perspectives on key workforce-related issues. The 2025 Managed Care Pharmacy Workforce Report represents a significant step toward a deeper understanding of the managed care pharmacy landscape.
